Association between antimicrobial resistance and virulence in Escherichia coli

Virulence

Volumn 3, Issue 1, 2012, Pages 18-28

  da Silva, Gabriela Jorge ^a   Mendonça, Nuno ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Animal; E. coli O157; Enterohemorrhagic E. coli; Extended spectrum lactamase; Extraintestinal pathogenic E. coli; Foodborne infections; Quinolone resistance; Shigatoxin; Uropathogenic; Virulence factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOXITIN; CEFTAZIDIME; COTRIMOXAZOLE; GENTAMICIN; NEOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLONE; ENTEROAGGREGATIVE ESCHERICHIA COLI; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; GENETIC LINKAGE; HUMAN; NONHUMAN; PHYLOGENY; PLASMID; REVIEW;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84858178203     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.3.1.18382     Document Type: Review

References (132)

1. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother 2009; 64:i3-i10; PMID:19675017; http://dx.doi.org/10.1093/jac/dkp256
2. Alanis AJ. Resistance to antibiotics: are we in the postantibiotic era? Arch Med Res 2005; 36:697-705; PMID:16216651; http://dx.doi.org/10.1016/j.arcmed.2005.06.009
3. Marshall BM, Levy SB. Food Animals and Antimicrobials: Impacts on Human Health. Clin Microbiol Rev 2011; 24:718-733; PMID:21976606; http://dx.doi.org/10.1128/CMR.00002-11
4. Ewers C, Antão EM, Diehl I, Philipp HC, Wieler LH. Intestine and environment of the chicken as reservoirs for extraintestinal pathogenic Escherichia coli strains with zoonotic potential. Appl Environ Microbiol 2009; 75:184-192; PMID:18997030; http://dx.doi.org/10.1128/AEM.01324-08
5. de Jong A, Bywater R, Butty P, Deroover E, Godinho K, Klein U, et al. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J Antimicrob Chemother 2009; 63:733-744; PMID:19233897; http://dx.doi.org/10.1093/jac/dkp012
6. O'Keefe A, Hutton TA, Schifferli DM, Rankin SC. First detection of CTX-M and SHV extended-spectrum betalactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob Agents Chemother 2010; 54:3489-3492; PMID:20479196; http://dx.doi.org/10.1128/AAC.01701-09
7. Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother 2008; 62(Suppl 1): i1-i9; PMID:18441341; http://dx.doi.org/10.1093/jac/dkn241
8. Rice LB. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009; 12:476-481; PMID:19716760; http://dx.doi.org/10.1016/j.mib.2009.08.001
9. McDonald LC. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment. Clin Infect Dis 2006; 42:S65-S71; PMID: 16355319; http://dx.doi.org/10.1086/499404
10. Boerlin P, Reid-Smith RJ. Antimicrobial resistance: its emergence and transmission. Anim Health Res Rev 2008; 9:115-1126; PMID:19102787; http://dx.doi.org/10.1017/S146625230800159X
11. Johnson TJ, Nolan LK. Pathogenomics of the virulence plasmids of Escherichia coli. Microbiol Mol Biol Rev 2009; 73:750-774; PMID:19946140; http://dx.doi.org/10.1128/MMBR.00015-09
12. Frost LS, Leplae R, Summers AO, Toussaint A. Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol 2005; 3:722-732; PMID:16138100; http://dx.doi.org/10.1038/nrmicro1235
13. Barlow M. What antimicrobial resistance has taught us about horizontal gene transfer. Methods Mol Biol 2009; 532:397-411; PMID:19271198; http://dx.doi.org/10.1007/978-1-60327-853-9_23
14. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005; 41:S120-S126; PMID:15942878; http://dx.doi.org/10.1086/428052
15. Malik M, Hoatam G, Chavda K, Kerns RJ, Drlica K. Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure. Antimicrob Agents Chemother2010; 54:149-156; PMID:19805561; http://dx.doi.org/10.1128/AAC.01035-09
16. Wozniak RA, Waldor MK. Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 2010; 8: 552-563; PMID:20601965; http://dx.doi.org/10.1038/nrmicro2382
17. Villa L, García-Fernández A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65:2518-2529; PMID:20935300; http://dx.doi.org/10.1093/jac/dkq347
18. Rasko DA, Rosovitz MJ, Myers GS, Mongodin EF, Fricke WF, Gajer P, et al. The pangenome structure of Escherichia coli: comparative genomic analysis of E. coli commensal and pathogenic isolates. J Bacteriol 2008; 190:6881-6893; PMID:18676672; http://dx.doi.org/10.1128/JB.00619-08
19. Johnson JR, Russo TA. Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections. J Infect Dis 2002; 186:859-864; PMID: 12198625; http://dx.doi.org/10.1086/342490
20. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli. J Lab Clin Med 2002; 139:155-162; PMID:11944026; http://dx.doi.org/10.1067/mlc.2002.121550
21. Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-140; PMID: 15040260; http://dx.doi.org/10.1038/nrmicro818
22. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 2010; 8:26-38; PMID:19966814
23. DiRita V. Enteric bacteria: secretory diarrhea. In: Engleberg, NC, DiRita V, Dermody TS, ed. Mechanisms of Microbial Disease. 4thed, Baltimore, MD: Lippincott Williams &Wilkins, 2007:190-199.
24. Di Rita V. Invasive and tissue-damaging enteric bacterial pathogens: bloody diahhhea and dysentery. In: Engleberg, NC, DiRita V, Dermody TS, ed. Mechanisms of Microbial Disease. 4thed, Baltimore, MD: Lippincott Williams & Wilkins, 2007:200-214.
25. Rolhion N, Darfeuille-Michaud A. Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis 2007; 13:1277-1283; PMID: 17476674; http://dx.doi.org/10.1002/ibd.20176
26. Schmidt MA. LEEways: tales of EPEC, ATEC and EHEC. Cell Microbiol 2010; 12:1544-1552; PMID: 20716205; http://dx.doi.org/10.1111/j.1462-5822.2010.01518.x
27. Smith JL, Fratamico PM, Gunther NW. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 2007; 4:134-163; PMID:17600482; http://dx.doi.org/10.1089/fpd.2007.0087
28. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67:546-553; PMID:9916057
29. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-4558; PMID:11010916; http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000
30. Paterson DL, Bonomo RA. Extended-spectrum-betalactamases: a clinical update. Clin Microbiol Rev 2005; 18:657-686; PMID:16223952; http://dx.doi.org/10.1128/CMR.18.4.657-686.2005
31. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990; 18:294-298; PMID:2276823; http://dx.doi.org/10.1007/BF01647010
32. Bonnet R. Growing group of extended spectrum betalactamases: the CTX-M-enzymes. Antimicrob Agents Chemother 2004; 48:1-14; PMID:14693512; http://dx.doi.org/10.1128/AAC.48.1.1-14.2004
33. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59:165-174; PMID:17158117; http://dx.doi.org/10.1093/jac/dkl483
34. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008; 14:195-200; PMID:18258110; http://dx.doi.org/10.3201/eid1402.070350
35. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4- ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-281; PMID:18077311; http://dx.doi.org/10.1093/jac/dkm464
36. Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35:316-321; PMID:20060273; http://dx.doi.org/10.1016/j.ijantimicag.2009.11.003
37. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, communityassociated strain. J Antimicrob Chemother 2011; 66: 1-14; PMID:21081548; http://dx.doi.org/10.1093/jac/dkq415
38. Barlow M, Reik RA, Jacobs SD, Medina M, Meyer MP, McGowan JE, Jr., et al. High rate of mobilization for blaCTX-Ms. Emerg Infect Dis 2008; 14:423-428; PMID:18325257; http://dx.doi.org/10.3201/eid1403.070405
39. Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol 2010; 8:207-217; PMID:20157339; http://dx.doi.org/10.1038/nrmicro2298
40. Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, et al. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis 2005; 11:54-61; PMID:15705323
41. Lee S, Yu JK, Park K, Oh EJ, Kim SY, Park YJ. Phylogenetic groups and virulence factors in pathogenic and commensal strains of Escherichia coli and their association with blaCTX-M. Ann Clin Lab Sci 2010; 40:361-367; PMID:20947811
42. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005; 49:4667-4670; PMID:16251310; http://dx.doi.org/10.1128/AAC.49.11.4667-4670.2005
43. Karisik E, Ellington MJ, Livermore DM, Woodford N. Virulence factors in Escherichia coli with CTX-M- 15 and other extended-spectrum b-lactamases in the UK. J Antimicrob Chemother 2008; 61:54-58; PMID: 17981835; http://dx.doi.org/10.1093/jac/dkm401
44. Calhau V, Lin T, Ribeiro G, Mendonça N, Da Silva G. Association of virulence markers and antimicrobial susceptibility in Escherichia coli clinical isolates. Clin Microbiol Infect 2011; 17(Suppl 4):S130.
45. Lavigne JP, Blanc-Potard AB, Bourg G, Moreau J, Chanal C, Bouziges N, et al. Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. Clin Microbiol Infect 2006; 12:1199-206; PMID:17121626; http://dx.doi.org/10.1111/j.1469-0691.2006.01536.x
46. Johnson JR, Goullet P, Picard B, Moseley SL, Roberts PL, Stamm WE. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect Immun 1991; 59:2311-2315; PMID:1675626
47. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, et al. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61:1024-1208; PMID:18334490; http://dx.doi.org/10.1093/jac/dkn084
48. Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 2006; 12:1034-1036; PMID:16961644; http://dx.doi.org/10.1111/j.1469-0691.2006.01543.x
49. Ghigo JM. Natural conjugative plasmids induce bacterial biofilm development. Nature 2001; 412:442-445; PMID:11473319; http://dx.doi.org/10.1038/35086581
50. Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, et al. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9- producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 2010; 76:6991-697; PMID:20817805; http://dx.doi.org/10.1128/AEM.01112-10
51. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 2009; 117:526-436; PMID:19594493; http://dx.doi.org/10.1111/j.1600-0463.2009.02465.x
52. Coelho A, Mora A, Mamani R, López C, González- López JJ, Larrosa MN, et al. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV- 12 with high virulence gene content in Barcelona (Spain). J Antimicrob Chemother 2011; 66:517-526; PMID: 21177675; http://dx.doi.org/10.1093/jac/dkq491
53. Dhanji H, Murphy NM, Akhigbe C, Doumith M, Hope R, Livermore DM, et al. Isolation of fluoroquinoloneresistant O25b:H4-ST131 Escherichia coli with CTXM- 14 extended-spectrum b-lactamase from UK river water. J Antimicrob Chemother 2011; 66:512-516; PMID: 21172781; http://dx.doi.org/10.1093/jac/dkq472
54. Dhanji H, Doumith M, Rooney PJ, O'Leary MC, Loughrey AC, Hope R, et al. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK. J Antimicrob Chemother 2011; 66:297-303; PMID:21131323; http://dx.doi.org/10.1093/jac/dkq463
55. Blanco J, Mora A, Mamani R, López C, Blanco M, Dahbi G, et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011; 66:2011-2021; PMID:21669946; http://dx.doi.org/10.1093/jac/dkr235
56. Cagnacci S, Gualco L, Debbia E, Schito GC, Marchese A. European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. J Clin Microbiol 2008; 46:2605-2612; PMID:18579721; http://dx.doi.org/10.1128/JCM.00640-08
57. Cerquetti M, Giufrè M, García-Fernández A, Accogli M, Fortini D, Luzzi I, et al. Ciprofloxacin resistant, CTX-M-15-producing Escherichia coli ST131 clone in extraintestinal infections in Italy. Clin Microbiol Infect 2010; 16:1555-1558; PMID:20121822; http://dx.doi.org/10.1111/j.1469-0691.2010.03162.x
58. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-b-lactamase- producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009; 53:2846-2851; PMID:19380595; http://dx.doi.org/10.1128/AAC.00247-09
59. Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 62:284-288; PMID:18453527; http://dx.doi.org/10.1093/jac/dkn181
60. Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008; 46:3900-3905; PMID:18842941; http://dx.doi.org/10.1128/JCM.00734-08
61. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51:286-294; PMID:20572763; http://dx.doi.org/10.1086/653932
62. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009; 53:2227-2238; PMID:19307361; http://dx.doi.org/10.1128/AAC.01707-08
63. Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum betalactamases. J Antimicrob Chemother 2009; 63:67-71; PMID:18931389; http://dx.doi.org/10.1093/jac/dkn428
64. Girlich D, Poirel L, Carattoli A, Kempf I, Lartigue MF, Bertini A, et al. Extended-spectrum beta-lactamase CTX-M-1 in Escherichia coli isolates from healthy poultry in France. Appl Environ Microbiol 2007; 73: 4681-4685; PMID:17513592; http://dx.doi.org/10.1128/AEM.02491-06
65. García-Fernández A, Chiaretto G, Bertini A, Villa L, Fortini D, Ricci A, et al. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. J Antimicrob Chemother 2008; 61: 1229-1233; PMID:18367460; http://dx.doi.org/10.1093/jac/dkn131
66. Kim SR, Komano T. The plasmid R64 thin pilus identified as a type IV pilus. J Bacteriol 1997; 179: 3594-3603; PMID:9171405
67. Szczepanowski R, Braun S, Riedel V, Schneiker S, Krahn I, Pühler A, et al. The 120 592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions. Microbiology 2005; 151:1095-111; PMID:15817778; http://dx.doi.org/10.1099/mic.0.27773-0
68. Garcillán-Barcia MP, de la Cruz F. Why is entry exclusion an essential feature of conjugative plasmids? Plasmid 2008; 60:1-18; PMID:18440635; http://dx.doi.org/10.1016/j.plasmid.2008.03.002
69. Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002; 15:647-679; PMID:12364374; http://dx.doi.org/10.1128/CMR.15.4.647-679.2002
70. Martínez-Martínez L, Fernández F, Perea EJ. Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother 1999; 43:277-279; PMID:11252335; http://dx.doi.org/10.1093/jac/43.2.277
71. Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186:1039-1042; PMID:12232848; http://dx.doi.org/10.1086/342955
72. Drews SJ, Poutanen SM, Mazzulli T, McGeer AJ, Sarabia A, Pong-Porter S, et al. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005; 43:4218-4220; PMID:16081983; http://dx.doi.org/10.1128/JCM.43.8.4218-4220.2005
73. Horcajada JP, Soto S, Gajewski A, Smithson A, Jiménez de Anta MT, Mensa J, et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43: 2962-2964; PMID:15956432; http://dx.doi.org/10.1128/JCM.43.6.2962-2964.2005
74. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000; 54: 641-679; PMID:11018140; http://dx.doi.org/10.1146/annurev.micro.54.1.641
75. Sabaté M, Moreno E, Pérez T, Andreu A, Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect 2006; 12:880-886; PMID:16882293; http://dx.doi.org/10.1111/j.1469-0691.2006.01461.x
76. Hacker J, Carniel E. Ecological fitness, genomic islands and bacterial pathogenicity. A Darwinian view of the evolution of microbes. EMBO Rep 2001; 2:376-381; PMID:11375927
77. Soto SM, Jimenez de Anta MT, Vila J. Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother 2006; 50:649-653; PMID:16436722; http://dx.doi.org/10.1128/AAC.50.2.649-653.2006
78. Blum G, Ott M, Lischewski A, Ritter A, Imrich H, Tschäpe H, et al. Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen. Infect Immun 1994; 62:606-614; PMID:7507897
79. Middendorf B, Hochhut B, Leipold K, Dobrindt U, Blum-Oehler G, Hacker J. Instability of pathogenicity islands in uropathogenic Escherichia coli 536. J Bacteriol 2004; 186:3086-3096; PMID:15126470; http://dx.doi.org/10.1128/JB.186.10.3086-3096.2004
80. Mendonça N, Calhau V, Lin T, Boaventura L, Ribeiro G, da Silva GJ. Unusual genotype of a uropathogenic Escherichia coli strain assigned to the B2 phylogenetic group. J Clin Microbiol 2011; 49:3105-3106; PMID: 21632899; http://dx.doi.org/10.1128/JCM.00585-11
81. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype. Antimicrob Agents Chemother 2005; 49:4739-4744; PMID:16251319; http://dx.doi.org/10.1128/AAC.49.11.4739-4744.2005
82. Johnson JR, Kuskowski MA, O'Bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005; 49:26-31; PMID:15616271; http://dx.doi.org/10.1128/AAC.49.1.26-31.2005
83. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobialsusceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis 2004; 190: 1739-1744; PMID:15499527; http://dx.doi.org/10.1086/425018
84. Ramchandani M, Manges AR. DebRoy C, Smith SP, Johnson JR, Riley LW. Possible animal origin of human-associated, multidrug-resistant, uropathogenic Escherichia coli. Clin Infect Dis 2005; 40:251-257; PMID:15655743; http://dx.doi.org/10.1086/426819
85. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 2008; 46:480-487; PMID:18057134; http://dx.doi.org/10.1128/JCM.01488-07
86. Escobar-Páramo P, Clermont O, Blanc-Potard AB, Bui H, Le Bouguénec C, Denamur E. A specific genetic background is required for acquisition and expression of virulence factors in Escherichia coli. Mol Biol Evol 2004; 21:1085-1094; PMID:15014151; http://dx.doi.org/10.1093/molbev/msh118
87. Takahashi A, Muratani T, Yasuda M, Takahashi S, Monden K, Ishikawa K, et al. Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns. J Clin Microbiol 2009; 47:791-795; PMID: 19158256; http://dx.doi.org/10.1128/JCM.01740-08
88. Hinton M, Kaukas A, Linton AH. The ecology of drug resistance in enteric bacteria. Soc Appl Bacteriol Symp Ser 1986; 15:77S-792S; PMID:3107136
89. de Jong A, Bywater R, Butty P, Deroover E, Godinho K, Klein U, et al. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J Antimicrob Chemother 2009; 63:733-744; PMID: 19233897; http://dx.doi.org/10.1093/jac/dkp012
90. Pomba C, da Fonseca JD, Baptista BC, Correia JD, Martínez-Martínez L. Detection of the pandemic O25-ST131 human virulent Escherichia coli CTXM- 15-producing clone harboring the qnrB2 and aac (6')-Ib-cr genes in a dog. Antimicrob Agents Chemother 2009; 53:327-328; PMID:19001117; http://dx.doi.org/10.1128/AAC.00896-08
91. Johnson JR, Clabots C, Kuskowski MA. Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol 2008; 46: 4078-4082; PMID:18945846; http://dx.doi.org/10.1128/JCM.00980-08
92. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. Sharing of Escherichia coli sequence type ST131 and other multidrugresistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol 2009; 47:3721-3725; PMID:19710261; http://dx.doi.org/10.1128/JCM.01581-09
93. Johnson JR, Johnston B, Clabots CR, Kuskowski MA, Roberts E. DebRoy C. Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol 2008; 46:417-422; PMID:18003805; http://dx.doi.org/10.1128/JCM.00674-07
94. Johnson JR, Clabots C. Sharing of virulent Escherichia coli clones among household members of a woman with acute cystitis. Clin Infect Dis 2006; 43:e101-e108;PMID:17051483; http://dx.doi.org/10.1086/508541
95. You JY, Moon BM, Oh IG, Baek BK, Li LG, Kim BS, et al. Antimicrobial resistance of Escherichia coli O157 from cattle in Korea. Int J Food Microbiol 2006; 106: 74-78; PMID:16300850; http://dx.doi.org/10.1016/j.ijfoodmicro.2005.05.013
96. Ateba CN, Bezuidenhout CC. Characterisation of Escherichia coli O157 strains from humans, cattle and pigs in the North-West Province, South Africa. Int J Food Microbiol 2008; 128:181-188; PMID:18848733; http://dx.doi.org/10.1016/j.ijfoodmicro.2008.08.011
97. Mora A, Blanco JE, Blanco M, Alonso MP, Dhabi G, Echeita A, et al. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res Microbiol 2005; 156:793-806; PMID:15921895; http://dx.doi.org/10.1016/j.resmic.2005.03.006
98. Radu S, Ling OW, Rusul G, Karim MI, Nishibuchi M. Detection of Escherichia coli O157:H7 by multiplex PCR and their characterization by plasmid profiling, antimicrobial resistance, RAPD and PFGE analyses. J Microbiol Methods 2001; 46:131-139; PMID:11412923; http://dx.doi.org/10.1016/S0167-7012(01)00269-X
99. Kim JY, Kim SH, Kwon NH, Bae WK, Lim JY, Koo HC, et al. Isolation and identification of Escherichia coli O157:H7 using different detection methods and molecular determination by multiplex PCR and RAPD. J Vet Sci 2005; 6:7-19; PMID:15785118
100. Galland JC, Hyatt DR, Crupper SS, Acheson DW. Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots. Appl Environ Microbiol 2001; 67:1619-1627; PMID:11282614; http://dx.doi.org/10.1128/AEM.67.4.1619-1627.2001
101. Manna SK, Brahmane MP, Manna C, Batabyal K, Das R. Occurrence, virulence characteristics and antimicrobial resistance of Escherichia coli O157 in slaughtered cattle and diarrhoeic calves in West Bengal, India. Lett Appl Microbiol 2006; 43:405-409; PMID:16965371; http://dx.doi.org/10.1111/j.1472-765X.2006.01975.x
102. Dutta S, Deb A, Chattopadhyay UK, Tsukamoto T. Isolation of Shiga toxin-producing Escherichia coli including O157:H7 strains from dairy cattle and beef samples marketed in Calcutta, India. J Med Microbiol 2000; 49:765-767; PMID:10933264
103. Adwan GM, Adwan KM. Isolation of shiga toxigenic Escherichia coli from raw beef in Palestine. Int J Food Microbiol 2004; 97:81-84; PMID:15527921; http://dx.doi.org/10.1016/j.ijfoodmicro.2004.03.032
104. Giammanco GM, Pignato S, Grimont F, Grimont PA, Caprioli A, Morabito S, et al. Characterization of Shiga toxin-producing Escherichia coli O157:H7 isolated in Italy and in France. J Clin Microbiol 2002; 40:4619-4624; PMID:12454162; http://dx.doi.org/10.1128/JCM.40.12.4619-4624.2002
105. Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011; 11:671-676; PMID:21703928
106. Abong'o BO, Momba MN, Mwambakana JN. Prevalence and antimicrobial susceptibility of Escherichia coli O157:H7 in vegetables sold in the Amathole District, Eastern Cape Province of South Africa. J Food Prot 2008; 71:816-819; PMID:18468039
107. Solecki O, MacRae M, Strachan N, Lindstedt BA, Ogden IE. Coli O157 from sheep in northeast Scotland: prevalence, concentration shed, and molecular characterization by multilocus variable tandem repeat analysis. Foodborne Pathog Dis 2009; 6:849-854; PMID: 19292688; http://dx.doi.org/10.1089/fpd.2008.0216
108. Ethelberg S, Lisby M, Bottiger B, Schultz AC, Villif A, Jensen T, et al. Outbreaks of gastroenteritis linked tolettuce, Denmark, January 2010. Euro Surveill 2010; 15:19484; PMID:20158982
109. Solomakos N, Govaris A, Angelidis AS, Pournaras S, Burriel AR, Kritas SK, et al. Occurrence, virulence genes and antibiotic resistance of Escherichia coli O157 isolated from raw bovine, caprine and ovine milk in Greece. Food Microbiol 2009; 26:865-8671; PMID: 19835773; http://dx.doi.org/10.1016/j.fm.2009.06.002
110. Staats JJ, Chengappa MM, DeBey MC, Fickbohm B, Oberst RD. Detection of Escherichia coli Shiga toxin (stx) and enterotoxin (estA and elt) genes in fecal samples from nondiarrheic and diarrheic greyhounds. Vet Microbiol 2003; 94:303-312; PMID:12829384; http://dx.doi.org/10.1016/S0378-1135(03)00134-2
111. Bentancor A, Rumi MV, Gentilini MV, Sardoy C, Irino K, Agostini A, et al. Shiga toxin-producing and attaching and effacing Escherichia coli in cats and dogs in a high hemolytic uremic syndrome incidence region in Argentina. FEMS Microbiol Lett 2007; 267:251-256; PMID:17328115; http://dx.doi.org/10.1111/j.1574-6968.2006.00569.x
112. Kataoka Y, Irie Y, Sawada T, Nakazawa M. A 3-year epidemiological surveillance of Escherichia coli O157: H7 in dogs and cats in Japan. J Vet Med Sci 2010; 72:791-794; PMID:20124764; http://dx.doi.org/10.1292/jvms.09-0439
113. Orden JA, Ruiz-Santa-Quiteria JA, Garcia S, Cid D, De La Fuente R. In vitro susceptibility of Escherichia coli strains isolated from diarrhoeic dairy calves to 15 antimicrobial agents. J Vet Med B Infect Dis Vet Public Health 2000; 47:329-335; PMID:10900823; http://dx.doi.org/10.1046/j.1439-0450.2000.00356.x
114. Cid D, Piriz S, Ruiz-Santa-Quiteria JA, Valle J, Vadillo S, de la Fuente R. In vitro susceptibility of Escherichia coli strains isolated from diarrhoeic lambs and goat kids to 14 antimicrobial agents. J Vet Pharmacol Ther 1996; 19:397-401; PMID:8905575; http://dx.doi.org/10.1111/j.1365-2885.1996.tb00070.x
115. González EA, Blanco J. Serotypes and antibiotic resistance of verotoxigenic (VTEC) and necrotizing (NTEC) Escherichia coli strains isolated from calves with diarrhoea. FEMS Microbiol Lett 1989; 51:31-36; PMID:2477304; http://dx.doi.org/10.1016/0378-1097(89)90072-4
116. Tarawneh KA, Al-Tawarah NM, Abdel-Ghani AH, Al-Majali AM, Khleifat KM. Characterization of verotoxigenic Escherichia coli (VTEC) isolates from faeces of small ruminants and environmental samples in southern Jordan. J Basic Microbiol 2009; 49:310-317; PMID:19025877; http://dx.doi.org/10.1002/jobm.200800060
117. Karama M, Johnson RP, Holtslander R, McEwen SA, Gyles CL. Prevalence and characterization of verotoxin- producing Escherichia coli (VTEC) in cattle from an Ontario abattoir. Can J Vet Res 2008; 72:297-302; PMID:18783017
118. Badri S, Fassouane A, Filliol I, Hassar M, Cohen N. Molecular typing of Escherichia coli strains isolated from food in Casablanca (Morocco). Cell Mol Biol (Noisy-le-grand) 2009; 55(Suppl):OL1132-OL1137; PMID: 19656466
119. Schroeder CM, Meng J, Zhao S, DebRoy C, Torcolini J, Zhao C, et al. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg Infect Dis 2002; 8: 1409-1414; PMID:12498656
120. Vali L, Hamouda A, Hoyle DV, Pearce MC, Whitaker LH, Jenkins C, et al. Antibiotic resistance and molecular epidemiology of Escherichia coli O26, O103 and O145 shed by two cohorts of Scottish beef cattle. J Antimicrob Chemother 2007; 59:403-410; PMID:17289773; http://dx.doi.org/10.1093/jac/dkl491
121. Srinivasan V, Nam HM, Sawant AA, Headrick SI, Nguyen LT, Oliver SP. Distribution of tetracycline and streptomycin resistance genes and class 1 integrons in Enterobacteriaceae isolated from dairy and non-dairy farm soils. Microb Ecol 2008; 55:184-193; PMID:17701242; http://dx.doi.org/10.1007/s00248-007-9266-6
122. Bae IK, Lee YN, Lee WG, Lee SH, Jeong SH. Novel complex class 1 integron bearing an ISCR1 element in an Escherichia coli isolate carrying the blaCTX-M-14 gene. Antimicrob Agents Chemother 2007; 51:3017-3019; PMID:17517851; http://dx.doi.org/10.1128/AAC.00279-07
123. Garcia-Aljaro C, Moreno E, Andreu A, Prats G, Blanch AR. Phylogroups, virulence determinants and antimicrobial resistance in stx(2) gene-carrying Escherichia coli isolated from aquatic environments. Res Microbiol 2009; 160:585-591; PMID:19723578; http://dx.doi.org/10.1016/j.resmic.2009.08.004
124. Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000; 181: 664-670; PMID:10669353; http://dx.doi.org/10.1086/315239
125. Sabaté M, Prats G, Moreno E, Balleste E, Blanch AR, Andreu A. Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater. Res Microbiol 2008; 159:288-293; PMID:18434099; http://dx.doi.org/10.1016/j.resmic.2008.02.001
126. Ngeleka M, Pritchard J, Appleyard G, Middleton DM, Fairbrother JM. Isolation and association of Escherichia coli AIDA-I/STb, rather than EAST1 pathotype, with diarrhea in piglets and antibiotic sensitivity of isolates. J Vet Diagn Invest 2003; 15:242-152; PMID:12735346; http://dx.doi.org/10.1177/104063870301500305
127. Ngeleka M, Kwaga JK, White DG, Whittam TS, Riddell C, Goodhope R, et al. Escherichia coli cellulites in broiler chickens: clonal relationships among strains and analysis of virulence-associated factors of isolates from diseased birds. Infect Immun 1996; 64:3118-3126; PMID:8757842
128. Wang XM, Liao XP, Zhang WJ, Jiang HX, Sun J, Zhang MJ, et al. Prevalence of serogroups, virulence genotypes, antimicrobial resistance, and phylogenetic background of avian pathogenic Escherichia coli in south of China. Foodborne Pathog Dis 2010; 7:1099-1106; PMID: 20618074; http://dx.doi.org/10.1089/fpd.2010.0542
129. Johnson TJ, Siek KE, Johnson SJ, Nolan LK. DNA sequence and comparative genomics of pAPEC-O2-R, an avian pathogenic Escherichia coli transmissible R plasmid. Antimicrob Agents Chemother 2005; 49: 4681-4688; PMID:16251312; http://dx.doi.org/10.1128/AAC.49.11.4681-4688.2005
130. Johnson TJ, Wannemeuhler YM, Scaccianoce JA, Johnson SJ, Nolan LK. Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob Agents Chemother 2006; 50:3929-3933; PMID:16940062; http://dx.doi.org/10.1128/AAC.00569-06
131. Kuhnert P, Boerlin P, Frey J. Target genes for virulence assessment of Escherichia coli isolates from water, food and the environment. FEMS Microbiol Rev 2000; 24: 107-117; PMID:10640601; http://dx.doi.org/10.1111/j.1574-6976.2000.tb00535.x
132. Manges AR, Smith SP, Lau BJ, Nuval CJ, Eisenberg JN, Dietrich PS, et al. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study. Foodborne Pathog Dis 2007; 4:419-431; PMID: 18041952; http://dx.doi.org/10.1089/fpd.2007.0026